All rights reserved.
47.13
0.00 (0.00%)
The technology sector (XLK) now trades near a 20x P/E, matching the S&P 500, while offering over 50% higher consensus long-term earnings growth. Recent market selloff, driven by geopolitical and macro concerns, presents a selective buying opportunity, especially in tech and certain high-yield names.
Top REIT investors are quietly repositioning their portfolios, revealing where the “smart money” sees opportunity. Several clear sector themes are emerging from recent 13F filings. But the biggest surprise may be how much top managers disagree on certain REITs.
IRVINE, Calif., March 18, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE: AHR) announced today that its board of directors has declared a quarterly distribution of $0.25 per share for the quarter ending March 31, 2026.
When most people are chasing dividends and safety, they often go for defensive stocks like consumer staples.
American Healthcare REIT is upgraded to Buy, driven by robust portfolio growth, favorable macro trends, and strong FFO/NOI performance. AHR's diversified US/UK portfolio, low leverage (D/E 0.50), and expanding development pipeline position it well versus peers. Despite weaker EBITDA margins and modest dividend yield (1.9%), AHR's price forecasts and analyst consensus support upside.
Most dividend investors seek solid passive income streams from quality dividend stocks.
American Healthcare REIT, Inc. (AHR) Presents at Citi's Miami Global Property CEO Conference 2026 Transcript
There is no data to display
IRVINE, Calif., Feb. 26, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE: AHR) (the "Company," "we," "our," "management," "us," or "AHR") is announcing today its fourth quarter and full year 2025 results and issuing full year 2026 guidance.
IRVINE, Calif., Feb. 4, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE: AHR) (the "Company," "we," "our," or "AHR") announced today that Danny Prosky, the Company's Chief Executive Officer and President, has taken a medical leave of absence, effective February 3, 2026, due to a recent medical event.
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE: CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE: SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions.
